about
Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab
P50
description
researcher ORCID ID = 0000-0002-2373-5419
@en
wetenschapper
@nl
name
Rachel L Delfanti
@ast
Rachel L Delfanti
@en
Rachel L Delfanti
@es
Rachel L Delfanti
@nl
type
label
Rachel L Delfanti
@ast
Rachel L Delfanti
@en
Rachel L Delfanti
@es
Rachel L Delfanti
@nl
prefLabel
Rachel L Delfanti
@ast
Rachel L Delfanti
@en
Rachel L Delfanti
@es
Rachel L Delfanti
@nl
P106
P1153
57191897479
P21
P31
P496
0000-0002-2373-5419